For example, one Evernorth update (Jan 2025) designated Wegovy as a preferred generic semaglutide product under Optum Rx (for UHC plans) ( [47] ), indicating PBMs may steer covered patients toward the same products at negotiated prices
even though social media is not necessarily representative, a large collection of posts may reflect additional concerns. Upcoming webinars The science of HMOs A novonesis webinar featuring new clinical findings and ESPGHAN highlights Novonesis From boosters to companions: GLP-1 in Food, Beverages and Supplements Rousselot Top Nutrition Trends 2027 Nutrition Insight
However, the children's pediatricians confirmed exclusion and inclusion criteria by completing the Pediatrician Form, which also provided details of general health and previous medical history and recommendation for participation in the trial
N Engl J Med 380(24):22952306 Kristensen SL, Rrth R, Jhund PS, Docherty KF, Sattar N, Preiss D et al (2019) Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Can You Switch Between GLP-1 Medications
Vascular targets for the treatment of portal hypertension